GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Primo Nutraceuticals Inc (OTCPK:BUGVF) » Definitions » Price-to-Owner-Earnings

Primo Nutraceuticals (Primo Nutraceuticals) Price-to-Owner-Earnings : (As of Jun. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Primo Nutraceuticals Price-to-Owner-Earnings?

As of today (2024-06-25), Primo Nutraceuticals's share price is $1.0E-6. Primo Nutraceuticals does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Primo Nutraceuticals's Price-to-Owner-Earnings or its related term are showing as below:


BUGVF's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.5
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-25), Primo Nutraceuticals's share price is $1.0E-6. Primo Nutraceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2020 was $-0.61. Therefore, Primo Nutraceuticals's PE Ratio for today is At Loss.

As of today (2024-06-25), Primo Nutraceuticals's share price is $1.0E-6. Primo Nutraceuticals's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.27. Therefore, Primo Nutraceuticals's PE Ratio without NRI for today is At Loss.


Primo Nutraceuticals Price-to-Owner-Earnings Historical Data

The historical data trend for Primo Nutraceuticals's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Primo Nutraceuticals Price-to-Owner-Earnings Chart

Primo Nutraceuticals Annual Data
Trend Jul16 Jul17 Jul18 Jul19
Price-to-Owner-Earnings
- - - -

Primo Nutraceuticals Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Primo Nutraceuticals's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Primo Nutraceuticals's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Primo Nutraceuticals's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Primo Nutraceuticals's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Primo Nutraceuticals's Price-to-Owner-Earnings falls into.



Primo Nutraceuticals Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Primo Nutraceuticals's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.0E-6/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Primo Nutraceuticals  (OTCPK:BUGVF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Primo Nutraceuticals Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Primo Nutraceuticals's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Primo Nutraceuticals (Primo Nutraceuticals) Business Description

Traded in Other Exchanges
N/A
Address
890 West Pender Street, Suite 440, Vancouver, BC, CAN, V6C 1J9
Primo Nutraceuticals Inc is engaged in the production, processing, retail and branding of cannabis and cannabis-related products. The company offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors.